To Clot, Or Not
Anticoagulants in the pipeline may overcome the drawbacks of well-entrenched drugs
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
August 16, 2010 Cover
Volume 88, Issue 33
Anticoagulants in the pipeline may overcome the drawbacks of well-entrenched drugs
Credit:
Anticoagulants in the pipeline may overcome the drawbacks of well-entrenched drugs
Congressional hearing probes safety and other provisions of bill to reform chemical control law
Individuals’ records of environmental exposures may yield clues to the causes of disease
Lab at Johnson Space Center preserves 40-year-old lunar samples for study
Jump in earnings in the second quarter might be difficult to maintain
Arctic region lava samples provide an unprecedented view of nascent Earth's geochemical evolution